Listed by the USPTO as SALMON, KATHERINE D
Tech Center 1600 • Art Units: 1634 1671 1681 1682 1683
This examiner grants 43% of resolved cases
SALMON, KATHERINE D is assigned to Tech Center 1600 and Art Unit 1634. The profile includes 798 resolved cases and a 42.9% allowance rate, indicating that a significant portion of the recorded matters did not reach allowance under the measured outcome. The 1471-day median to allowance is also extended, so applicants should plan for continued prosecution activity and preserve options for claim revisions.
The interview lift is 37.7%, a strong positive association in the available record. Practitioners may therefore consider interviews early when they can frame a specific distinction over the cited art or clarify an examiner concern. The leading companies are Northwestern University, Illumina Inc., and Exact Sciences Corporation. Listed firms include Casimir Jones, S.C., FOLEY & LARDNER LLP, and MARSHALL, GERSTEIN & BORUN LLP.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18023598 | PREDICTION OF A RESPONSE OF A PROSTATE CANCER SUBJECT TO THERAPY OR PERSONALIZATION OF THERAPY OF A PROSTATE CANCER SUBJECT | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 17877664 | COMPOSITIONS AND METHODS FOR ANALYSIS USING NUCLEIC ACID PROBES AND BLOCKING SEQUENCES | Non-Final OA | 10x Genomics, Inc. |
| 18787942 | METHODS AND COMPOSITIONS FOR METHYLATION AND CHEMICALLY MODIFYING ASSISTED TAILORABLE ENDS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18261874 | METHODS FOR DETECTING utDNA | Final Rejection | Washington University |
| 17984444 | SURFACE-ENHANCED RAMAN SCATTERING (SERS) BIOSENSOR FOR DIAGNOSING PROSTATE CANCER WITH HIGH SENSITIVITY | Non-Final OA | Korea University Research and Business Foundation |
| 18427553 | Systems for Processing a Cellular Sample, Multi-Microwell Array-Flowcell Cartridges for Use Therein, and Methods of Use Thereof | Final Rejection | Becton, Dickinson and Company |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy42.9% of resolved applications examined by Katherine D Salmon were allowed (798 resolved cases), compared with 30.4% across Art Unit 1634 over the last five years.
This examiner's interview lift is +37.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Katherine D Salmon took 1,471 days on average from filing to allowance.
Katherine D Salmon examines applications in Art Unit 1634 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
